Barclays Capital Securities Limited

Reference number: 124431

Instant download

Authorised by the FCA

This firm is on the FCA register and authorised to carry out regulated activities.

Identity

Check their details

Compare these against whatever you were given. Scammers clone real firm names and reference numbers but use their own phone number and website, so a detail that does not match the register is the clearest warning sign there is.

Company details

From the company's Companies House record.

Company number
01929333
Company status
Active
Company type
Private limited company
Incorporated
9 July 1985 (41 years old)
Registered office
Matches the FCA register address ✓
Nature of business
  • Financial intermediation not elsewhere classified (SIC 64999)

Current directors and secretaries

Name Role Born Appointed
Dawn Fitzpatrick Director Feb 1970 27 Sep 2021
Robert Berry Director May 1964 1 May 2022
Makram Fares Director Mar 1974 20 Feb 2024
Menasey Marc Moses Director Nov 1957 1 Jan 2025
Robert Abdel-Malak Director Jul 1976 24 Oct 2025
BARCOSEC LIMITED Corporate secretary Not published 6 Oct 1998

Check on the FCA register → Report a scam →

Activities and protection

What they can do, and how you are protected

  • Hold or safeguard your money · Manage or trade investments · Run or oversee funds FSCS may apply
    Eligible investment and pension claims are typically FSCS-protected up to £85,000 per person, depending on the product and your circumstances.

    Check your FSCS cover →

  • Give regulated advice FSCS may apply
    A claim for unsuitable advice is itself FSCS-protected, up to the limit that applies to the product you were advised on.
Show FCA detail (12 permissions)
  • Acting as trustee or depositary of an unauthorised AIF
  • Advising on investments (except on Pension Transfers and Pension Opt Outs)
  • Advising on P2P agreements
  • Arranging (bringing about) deals in investments
  • Arranging safeguarding and administration of assets
  • Causing dematerialised instructions to be sent
  • Dealing in investments as agent
  • Dealing in investments as principal
  • Making arrangements with a view to transactions in investments
  • Managing investments
  • Safeguarding and administration of assets (without arranging)
  • Sending dematerialised instructions

Limits on what they may do

  • Access to the electoral register
    The firm shall access the full electoral register, where this is the most cost-effective way of verifying identity for anti-money laundering purposes and will not prejudice the interests of the customer, in order to carry out the current customer review exercise.
2 supervisory conditions set by the FCA

These are conditions the FCA places on the firm itself, covering things like capital it must hold and what it must report. They do not change what the firm may do for you.

  • Requirement to the IMM Permission 1713271
    Capital buffer requirement 1. The IMM Permission is subject to the requirement that, in relation to exposures to power and gas products: 1.1. The firm must hold a capital buffer as an adjustment to its capital resources requirement corresponding to at least 10% of the risk weighted exposure amount calculated under the IMM Permission; 1.2. This capital buffer must be held until the firm extends its simulation methodology to account for seasonal volatility; and 1.3. The firm must continuously monitor the impact of seasonal volatility on its material risk factors. Repurchase transactions 2. The IMM Permission is subject to the requirement that if the firm's exposures to repurchase transactions which are committed become material in size and risk, it must either treat them as fully drawn for exposure measurement and capital purposes or demonstrate to the PRA that the relevant model covered by the IMM Permission appropriately reflects the risks inherent in their contractual terms. Reporting requirements 3. The firm must collect, record, and report to the PRA the following information on a quarterly basis in each calendar year: 3.1. its counterparty credit risk (CCR) EAD and CCR RWAs at aggregate level, and divided by exposure type (OTC derivatives, listed derivatives, repurchase transactions, securities or commodities lending or borrowing transactions and margin lending transactions); 3.2. its exposures divided by exposure type, counterparty sector and by counterparty credit rating, showing both level and trend; 3.3. the composition of collateral for OTC derivatives, showing both average level of collateral types and trend by collateral type; 3.4. backtesting results on representative (actual or hypothetical) counterparty portfolios, including the results on the following: * 10, 20 or 40-day backtesting for collateralised transactions of OTC derivatives; * 5, 10 or 20-day backtesting for repurchase transactions, securities or commodities lending or borrowing transactions and margin lending transactions; and * backtesting over at least a year for representative uncollateralised transactions; 3.5. where the model relies on mapping to proxy transactions, or on proxy market data, a list of the affected products showing both the level and trend of these products and the results of the analysis to estimate the appropriateness of proxies for counterparty credit risk exposure calculation. 3.6. the results and analysis performed to calculate all capital adjustments held where there are identified limitations in the firm's CCR models and processes. 4. The firm must inform the PRA of any event that may have a significant impact on its IMM permission, including in particular: 4.1. changes to the list of asset classes, products or counterparties listed in Table 2 of Annex 1; 4.2. use of a different model for exposure calculations under the IMM permission; 4.3. changes to governance or senior management arrangements in relation to the IMM permission; 4.4. changes to the volumes or trends of trading for assets classes, products or counterparties listed in Table 2 of Annex 1; and 4.5. changes to the volumes or trends of trading for legal entities in the scope of the IMM permission. 5. For power and gas products: * the proportion of products using proxies; * the proportion of exposure attributable to proxied products. Maintenance of the group 6. This permission applies to each firm for as long as they remain part of the group headed by Barclays PLC.
  • Requirements added to Art 325 Permission (2227407)
    1. This Market Risk Consolidation Permission applies to an institution or undertaking listed in Table 1 only for as long as it remains part of the Barclays Group. The firm must notify the PRA promptly if any of those institutions or undertakings ceases to be part of the Barclays Group. 2. The firm must, no later than 23 business days after the end of each quarter, ending March, June, September and December submit, in respect of that quarter, a report to the PRA highlighting the capital impact of market risk consolidation for each of the institutions listed in Table 1. 3. The firm must: 1. ensure that any existing legal agreements or arrangements necessary for fulfilment of the conditions of Article 325(2) of the CRR as between any of the institutions in Table 1 are maintained; and 2. notify the PRA of any variation in the terms of such agreements, or of any change in the relevant legal or regulatory framework of which it becomes aware and which may have an impact on the ability of any of the institutions listed in Table 1 to meet the conditions of Article 325(2) of the CRR.

Complaints: You can refer a complaint about this firm to the Financial Ombudsman Service for free, whichever activity it relates to.

Track record

Action taken against them

2 fines between 2009 and 2011, £3.58m in total. This is part of the official register record and is worth reviewing before going ahead.

  • Fined £1.13m on 26 January 2011
    On 24 January 2011 the FSA imposed a financial penalty of £1,127,559 on Barclays Capital Securities Limited (the Firm, or Barclays Capital) for a breach of Principle 10 (Clients' assets) of the FSA's Principles for Businesses and Rules in the Client Assets sourcebook (CASS) which occurred between 1 December 2001 and 29 December 2010 (the Relevant Period). Specifically, Barclays Capital failed to segregate client money placed on GBP money market deposits intra-day in a segregated trust account, instead co-mingling the client money with its own funds throughout the Relevant Period. The funds were segregated overnight throughout the Relevant Period. The Firm agreed to settle at an early stage of the FSA's investigation. It therefore qualified for a 30% (stage 1) reduction in penalty, pursuant to the FSA's executive settlement procedures. Were it not for this discount, the FSA would have imposed a financial penalty of £1,610,799 on the Firm. The FSA views the failings as particularly serious because: 1. Barclays Capital has a leading market presence both in the United Kingdom and globally; 2. the failure to segregate and, therefore, adequately protect client money intra-day in accordance with the Client Money Rules remained undetected for over eight years; and 3. during the Relevant Period: a. the average daily amount of client money which was not segregated on an intra-day basis held on an annual basis increased from approximately £6 million in 2002 to approximately £387 million in 2009; and b. the highest amount held in the account and at risk at any one time was £752 million. Barclays Capital's failure to segregate client money intra-day for over eight years posed a significant risk of loss to its clients in the event that Barclays Capital became insolvent intra-day during the Relevant Period. If Barclays Capital had become insolvent intra-day there was the risk that its clients would have been classed as general unsecured creditors in the insolvency process rather than having the right to claim their money from a pool of protected client money. Further, in the event of Barclays Capital's insolvency, the co-mingling of client money and Barclays Capital's own funds would have hindered the ability to accurately trace client money. Consequently, the likelihood of such clients recovering their money in the event of the insolvency of Barclays Capital would have been reduced. Barclays Capital's failures therefore merit the imposition of a significant financial penalty. In determining the level of financial penalty, the FSA has taken into account a number of factors, including: 1. only one of the client money market accounts used by Barclays Capital was affected; 2. upon discovery of the issue by Barclays Capital, the Firm corrected the situation promptly; 3. Barclays Capital instigated a review of its compliance with Client Money Rules at its own initiative (the CASS Review); 4. the failure to segregate client money did not result in any incorrect financial reporting by Barclays Capital during the Relevant Period or in any loss to clients of Barclays Capital; 5. the FSA does not consider that Barclays Capital committed the breach deliberately or recklessly; and 6. Barclays Capital co-operated fully with the FSA during its investigation.
  • Fined £2.45m on 8 September 2009
    On 19 August 2009, the FSA imposed a penalty on Barclays Bank plc and Barclays Capital Securities Limited (Barclays) of £2,450,000 (discounted from £3,500,000 for early settlement) in respect of breaches of SUP 17 of the FSA Handbook and breaches of Principles 2 and 3 of the FSA's Principles for Businesses which occurred between 1 October 2006 and 31 October 2008. The breach of SUP 17 related to Barclays failure to submit accurate transaction reports as required in respect of an estimated 57.5 million transactions. Barclays breached Principle 2 by failing to conduct its business with due skill, care and diligence in failing to respond sufficiently to opportunities to review the adequacy of its transaction reporting systems. Barclays breached Principle 3 by failing to take reasonable care to organise and control its affairs responsibly and effectively, with adequate risk management systems, to meet the requirements to submit accurate transaction reports to the FSA.

Previously registered as

The FCA register holds 2 earlier registered names for this firm. A registered name changes when a firm rebrands, and a partnership's changes whenever its partners do.

  • Barclays De Zoete Wedd Securities Ltd
  • BZW Securities Ltd

Download this page as a PDF report

£5 for a clean, timestamped copy you can keep, file or send on. It also helps keep the site free to use and free of ads.

Instant download

Common questions

Frequently asked questions

Is Barclays Capital Securities Limited FCA authorised?
Yes, Barclays Capital Securities Limited (FRN 124431) is authorised by the FCA to carry out regulated activities.
Is my money safe with Barclays Capital Securities?
It depends on the product, but eligible claims may be protected by the FSCS. You can also refer complaints about Barclays Capital Securities to the Financial Ombudsman Service, free of charge.
Is Barclays Capital Securities a scam or clone?
Barclays Capital Securities is a genuine FCA-listed firm. However, scammers sometimes clone authorised firms. Always check that the contact details you were given match those on the FCA register before sending money or sharing information.
What is Barclays Capital Securities's Firm Reference Number (FRN)?
Barclays Capital Securities's FRN is 124431. You can verify it on the FCA register.